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Summary 
Human and mouse brain tissues obtained through National Neuroscience 
Institute (Singapore) were submitted to record 1D HRMAS 1H NMR and 2D 1H-1H 
COSY and 1H-13C HSQC spectra. Using 2D COSY and HSQC spectra to identify 
metabolites, comparing two human brain samples, three significant differences were 
observed. It suggests the possibility of differentiating brain tumors by analyzing 
metabolites using NMR technique.  
1D HRMAS 1H NMR spectra of both human and mouse brain tissue were 
used to calculate the concentration of major brain metabolites. The absolute amounts 
of 7 major metabolites in each sample were calculated for 20 brain tissues. New 
method using Matlab program to fit the curves of metabolites was demonstrated. 
HRMAS 1H NMR technique has been proved that it is suitable for quantitative 
analysis of brain tissues. Furthermore the calculation becomes straightforward by 
using Matlab.  
To determine the 3D structures of protein ec314, various 2D and 3D NMR 
spectra were recorded. Using 2D 1H-15N HSQC spectrum as reference, 3D 
hetero-nuclear experiments HNCACB and CACB(CO)NH were combined to 
sequentially assign backbone atoms. Aliphatic side chain carbon and proton spin 
system were assigned and connected to the sequentially assigned backbone 
resonances by using C(CO)NH, H(CCO)NH and HCCH-TOSCY spectral. Chemical 
Shift Index and NOE patterns were used to identify secondary structures.  
The 3D structure of protein ec314 was calculated using NOE restraints, 
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hydrogen bond restraints and dihedral angle restraints. The final structure shows 
ec314 is composed by 3 helices. It is similar to the C-terminal domain of E. coli RecA 
protein.  
 v
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1.1 Introduction to brain metabolites studies 
Nuclear magnetic resonance phenomenon was first detected by Bloch and 
Purcell independently in 1946 (Bloch, 1946; Purcell, 1946). They found that when 
certain nuclei were placed in a magnetic field and is subjected to radiofrequency at the 
appropriate frequency, they absorbed the energy and re-emitted this energy when 
transition of the nuclei from high energy level to their original state. The energy 
absorbed by the nuclear spins induces a voltage that can be detected by a suitably 
tuned coil of wire, amplified and then the signal displayed as free induction decay.  
The most important fundamental parameter in NMR spectroscopy is chemical 
shift firstly observed by Knight in 1949 (Knight, 1949). It is defined as the nuclear 
shielding divided by the applied field and depends only on the sample conditions 
(solvent, concentration, temperature) and not on the spectrometer frequency, which 
means in NMR spectroscopy, each nucleus gives rise to a resonance which is 
characterized by chemical shift reflecting its unique chemical environment. Thus 
chemical shift becomes an important parameter for identifying individual nucleus and 
assigning the resonance in the spectra to its corresponding site in chemical structure.  
NMR spectroscopy was firstly used for structural determination of small 
molecules in organic chemistry. Afterwards with the rapid development of NMR 
technique, NMR has been widely used in many different fields such as clinical 
research, macromolecule characterization. At the beginning of the 1980s, while NMR 
imaging became clinically feasible, after its introduction in the 1970s, whole-body 
 1
magnets of adequate field strength and homogeneity were constructed. Almost at the 
same period, NMR techniques suitable for in vivo studies were developed (Burtscher, 
2001).  
Today, nuclear magnetic resonance spectroscopy (MRS abbreviated by clinical 
researchers) has been widely used in clinical research as a unique tool for providing 
noninvasive access and measurements of important endogenous metabolically active 
compounds throughout the body, including the brain (Akihiro, 2000). Theoretically, 
almost all tissues and organs studied by NMR imaging can be studied by proton-MRS. 
However, the brain has by tradition been one of the organs most studied by in vivo 
1H-MRS, mainly due to its well-suited MRS properties. The brain is the organ in 
which functional differentiation among regions is most advanced. It is, moreover, one 
of the tissues of the body that exhibits very high levels of metabolism. Therefore 
physiologic and biochemical information concerning the kinetics and metabolism of 
substances as well as anatomical and morphological information must be evaluated 
for clarification of normal functions of the brain and clinical diagnosis. 
An advantageous property of NMR that plays an important role in medical 
applications is the low energy of the radio frequency quanta used (Hausser, 1991). 
Even with the highest magnetic fields applied nowadays, their energy of about 
4*10-25J is considerably below the energies required to crack a covalent chemical 
bond, with typical bond energies of the order of 10-17 J. Hence, NMR is a 
non-destructive method in contrast to other methods that use ionizing radiation. 
Due to its high sensitivity and ability to detect numerous tissue metabolites, 
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proton MRS has become well established as a non-invasive technique for studies of 
biological systems in vivo and in vitro. Quantitation of the NMR-observable 
metabolites can provide considerable biochemical information, and can help clinical 
investigators in understanding the role of metabolites in normal and pathological 
conditions. In recent years the biomedical and in vivo applications of 1H spectroscopy 
have increased, in part due to the increased availability of high magnetic field 
strengths and improved spectrometer performance. 
Applying magic-angle spinning (MAS) in proton MRS can reduce the spectral 
line-widths significantly. In liquids, molecules do not experience significant motion 
restriction and tumble at rates faster than the NMR time scale. Thus, spectral 
broadening effects due to molecular interactions are averaged, resulting in narrow 
spectral lines. In tissues, restriction of molecular motions and magnetic susceptibility 
results in spectral broadening that is not effectively averaged. As a consequence, 
tissues may be considered to have certain characteristics of solid molecular 
interactions. In solids, interactions such as dipole couplings and chemical shift 
anisotropy produce spectral broadening with an angular dependence of (3cos2θ-1), 
where θ is the magic angle and equal to 54.7°. When the sample was rotated around 
an axis at a magic-angle 54.7° with respect to the static field direction, the line-widths 
of the spectra reduced dramatically (Cheng, 1997). Currently, MAS is applied 
routinely in most high-resolution solid-state NMR experiments, and spinning 
frequencies continue to increase dramatically with increasing B0. 
As a biochemistry-based and quantitative method, high-resolution solid state 
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magic-angle spinning proton MRS (HRMAS 1HMRS) is suitable as a tool for 
experimental and clinical neuron-pathologic investigations. The significant advantage 
of HRMAS 1HMRS is that it’s rapid, nondestructive and requires only small amounts 
of unprocessed samples. Unlike chemical extraction or other forms of tissue 
processing, this method analyzes tissue directly, thus minimizing artifacts. 
One difficulty associated with in vivo proton spectroscopy is the identification 
and the measurement of individual metabolite contributions in spectra (Govindaraju, 
2000). This is largely due to the presence of numerous unresolved multiplet groups 
exhibiting complex line shapes and considerable spectral overlap, which is 
particularly severe at the lower B0 field strengths that are commonly available for 
studies in humans. Along with the application of 2D 1H-13C HSQC spectrum, the 
problem of overlap has been resolved. HSQC spectrum allows one to assign both 
proton and carbon chemical shift of the metabolites, thus most metabolites can be 
assigned unambiguously. 
Additional difficulties are caused by variable spectral patterns caused by 
susceptibility-induced line-shape distortions, the presence of broad uncharacterized 
resonances from macromolecules, lipids and unsuppressed water, and low 
signal-to-noise ratios. The analysis of such data is greatly facilitated by incorporating 
priori spectral information in a parametric modeling approach. 
Chemical shift and signal intensity are suitable for identification and 
quantitation of singlet resonances observed at any field strength. For compounds 
having multiple resonances, additional priori information is available in terms of fixed 
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frequency separations and relative amplitudes of the individual resonances belonging 
to each compound. However, unless some form of spectral-editing acquisition method 
is used to obtain a simplified spectrum, additional care is required for the analysis of 
compounds exhibiting multiplet resonances from spin-coupled nuclei. For these cases, 
identification using individual resonance frequencies is not only strongly field 
dependent, but also requires information on the phase of the individual resonances, 
which may be altered when using multiple-pulse spatial localization sequences.  
Due to higher sensitivity and better signal separation inverse correlated 2D-1H, 
13C NMR experiment offers much more information compared to standard proton or 
13C spectra. It correlates proton and attached carbon atom to provide both 1H and 13C 
chemical shifts of each group within a compound. Therefore 2D experiments are more 
powerful for identification of metabolites. 
The development of more advanced MRS sequences and their implementation 
by clinical MR units have made it possible to obtain proton spectra from brain tumors 
in the course of a clinical MRI examination and this has increased acceptance of MRS 
as a possible diagnostic tool. Furthermore the application of 2D hetero-nuclear NMR 
experiment improves the preciseness of the characterization of brain metabolites. 
The spatial distribution of key energy metabolites, such as adenosine 
triphosphate (ATP), phophorylated and unphosphorylated creatine, lactate, glucose, 
glycogen and fatty acid energy reserves, and compounds associated with neuronal 
function including glutamate, glutamine, γ-aminobutyric acid (GABA), and 
N-acetylaspartate, a putative neuronal maker, are all currently observable via 
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phosphorus (31P), hydrogen (1H), and carbon (13C) MRS. In addition to measuring the 
static levels of these compounds, dynamic measurements of metabolic flux and 
response to stimuli are observable by monitoring reactants and products by MRS 
(Akihiro, 2000). Thus, to the extent that these substances and parameters play key 
roles in brain function, the advent of spatially localized MRS opens a potential 
flood-gate of rich information about normal and disease process involving these 
substances. MRS is a fundamentally new method of probing brain function.  
In brain metabolite studies by NMR spectroscopy, selected compounds are 
low molecular weight and may be present with effective proton concentrations of 
approximately 0.5mmol per kg of wet weight (kgww) or higher, either in normal brain 
or following increases with disease (Varanavasi, 2000). And only L-amino acids are 
considered. Measurement of NMR parameters is limited to conditions of normal brain 
pH and temperature, while identifying those molecular groups for which pH or 
temperature dependent changes may be expected over a physiologically relevant 
range. Most studied metabolites in brain are Acetate, N-Acetyl aspartate (NAA), 
N-Acetylaspartylglutamate (NAAG), Alanine, Choline, Creatine, Glutamate, Glycine, 
Myo-inositol, Lactate, Pyruvate, Serine, Threonine, Tyrosine and Valine.  
Acetate is an essential building block for synthesis of a number of compounds. 
Its presence has been reported in several cell cultures and extracts, though its 
abundance was questioned as a possible artifact of the sample preparation. Acetate 
concentrations in human brain were observed to increase in brain tumors, ischemia, 
and in vivo in brain abscesses (Martin, 1994). Acetate is a simple molecule containing 
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a single CH3 group that provides a singlet at 1.90 ppm, which is shifted downfield at 
lower pH.  
NAA was found in the central nervous system of vertebrates in high 
concentration by Tallan et al. in 1956. NAA is thought of as a marker of 
neuronal/axonal density and viability (Birken, 1989). Although knowledge of its 
functional role is limited, loss of or decrease in NAA is generally seen in diseases 
associated with loss of neurons or axonal injury. NAA has seven protons that give 
NMR signals between 2.0 and 8.0 ppm. It typically provides the most prominent 
resonance, a singlet at 2.01 ppm, from the three protons of an N-acetyl CH3 group. In 
1D in vivo spectrum at lower field strengths, this resonance may also contain smaller 
contributions from NAAG, though this can be separated at higher field strengths or by 
using 2D methods. NAA also has three doublet-of-doublets centered at 2.49, 2.67 and 
4.38 ppm that correspond to the protons of aspartate CH2 and CH groups.  
Alanine, a nonessential amino acid that contains a methyl group, is present in 
the human brain at approximately 0.5mmol/kgww (Provencher, 1993). Increased 
alanine has been observed in vivo in meningiomas and following ischemia. The CH3 
and CH protons of alanine form a weakly coupled AX3 system with a doublet at 1.47 
ppm and a quartet at 3.77 ppm.  
Choline is an essential nutrient that is mainly obtained in the form of 
phospholipids from the diet. It is required for synthesis of the neurotransmitter 
acetylcholine, and of phosphatidylchoine, a major constituent of membranes (Pouwels, 
1998). For MRS studies on tissues, the choline signal is primarily observed as a 
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singlet at 3.2ppm that includes contributions from free choline, glycerol-phosphoryl 
choline (GPC), and phosphoryl choline (PC), and it is often referred to as ‘total 
choline’. The total NMR observable choline concentration in human brain is 
approximately 1-2mmol/kgww, and known to be non-uniformly distributed.  
Creatine and phosphocreatine (PCr) are present in brain, muscle, and blood. 
The synthesis of creatine takes place in the kidney and liver. It is reduced in the brain 
of patients with brain tumor or infectious brain masses (Wang, 1998). In vivo NMR 
measurements in brain observe the total of both creatine and phosphocreatine as 
prominent singlet resonance from their methyl-protons, at 3.03 ppm. 
Glutamate is the most abundant amino acid found in human brain at a 
concentration of approximately 12mmol/kgww. It is known to act as an excitatory 
neurotransmitter, although believed to have other functions (Ross, 1991). The signal 
from the single proton of the methine group is spread over as a doublet-of-doublets 
centered at 3.74 ppm.  
Of the nine isomers of inositol (Cerdan, 1985), myo-inositol is the 
predominate form found in tissue. The function of myo-inositol is not well understood, 
although it is believed to be an essential requirement for cell growth, an osmolite, and 
a storage form for glucose. Normal concentrations range from 4 to 8mmol/kgww, and 
altered levels have been associated with Alzheimer’s disease, hepatic encephalopathy 
and brain injury. This compound gives four groups of resonances. A 
doublet-of-doublet centered at 3.52 ppm and a triplet at 3.61 ppm are the two 
prominent mutliplets each corresponding to two protons. A triplet at 3.27 ppm is 
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typically hidden under choline, and another at 4.05 ppm is typically not observed 
because of water suppression.  
Lactate is the end product of anaerobic glycolysis, normally present in brain 
tissue at low concentrations and therefore generally not observed by in vivo MRS 
studies. Brain lactate is a marker for inadequate oxygen supply to tissues. Its 
concentration in brain tissues increases when oxygen is deficient or energy 
requirement increases, and when irreversible damage is caused by persistence of 
pathological conditions. The methyl and methane groups of lactate form an A3X spin 
system and detection is commonly carried out via the doublet from the methyl group, 
at 1.31 ppm.  
Intracranial neoplasms, brain tumors, have extensively been studied with in 
vitro and in vivo MRS (Burtscher, 2001). It has been shown that spectral patterns 
revealed by MRS in tumor tissue differ from those of normal brain. Spectral changes 
often shown in brain tumors are the increase in choline, decrease in or absence of 
NAA and the presence of lactate or lipids. Recent reports support that MRS can be 
useful in clinical practice for differentiating between certain brain tumors, based on 
changes in metabolite ratios across the lesion and the surrounding tissue. The changes 
of lactate/AA ratio from varies type of brain abscesses make it possible to 
differentiate anaerobic from aerobic or sterile brain abscesses on the basis of 
metabolite patterns observed at in vivo proton MR spectroscopy. Clinical research 
also found that an excellent correlation between neuronal loss shown by traditional 
neuron-histopathology and decrease of neuronal marker NAA measured by proton 
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MRS.  
Recent researches support that 1HMRS can be useful in clinical practice for 
differentiating between certain brain tumors, based on changes in metabolite ratios 
across the lesion and the surrounding tissue (Cheng, 1997). It has been shown that 
spectral patterns revealed by MRS in tumor tissue differ from those of normal brain. 
Spectral changes often shown in brain tumors are increase in choline, decrease in or 
absence of NAA and the presence of Lactate or lipids. An excellent correlation 
between regional neuron loss and regional NAA decrease was found. Furthermore, the 
disappearance of the metabolites of bacterial origin after aspiration observed by 
comparing NMR spectrum before and after therapy suggests a positive response to 
combined therapy.  
Recent years the incident of brain diseases varies from 1 to 2% in developed 
countries to 8% in developing countries. With the emergence of acquired 
immunodeficiency syndrome the incidence of brain abscesses is on the increase 
worldwide (Dev, 1998). It may be the most important thing in clinical medicine to 
detect and diagnose type of brain diseases at the beginning. The more efficient and 
accurate the diagnosis is made, the higher the possibility for the patient to be cured. 
Therefore it is significant to discover a new method for early detection and diagnosis 
of brain diseases.  
In our study, both 2D HSQC and COSY experiments have been done for 
identification of metabolites. Furthermore, the HRMAS 1HMRS experiment has been 
done. By fitting the curves of HRMAS 1HMRS using Matlab program, the exact 
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concentrations of major brain metabolites can be calculated. By analyzing 
combination of several NMR spectra, the differences in metabolites and their 
concentrations in brain can be observed. Based on these differences, brain tumor 
metabolites may become new evidence to differentiate brain tumors.  
 
1.2 Introduction to NMR structural studies of proteins 
NMR spectroscopy and X-ray crystallography currently are the only two 
techniques capable of determining the three dimensional molecular structure of 
protein at atomic resolution. NMR measurements are carried out in solution under 
natural physiological conditions, whereas X-ray crystallography requires single 
crystal. Furthermore NMR spectroscopy can investigate time-dependent phenomena, 
including reaction kinetics and intra-molecular dynamics of macromolecules. 
Additionally, NMR is efficient in determining ligand binding and mapping interaction 
surfaces of protein/ligand complexes.  
Since first three-dimensional protein solution structure was solved in 1980’s 
(Wüthrich, 1986), numerous protein structures have been solved by NMR and 
important protein functions have been revealed by protein dynamic studies. 
Nowadays, with routine NMR techniques, NMR spectroscopy can be applied to 
determine structures of proteins with medium or large size. This achievement depends 
on the rapid developments in various areas. With the development of high-field 
superconducting magnets and improvement in radiofrequency electronic and NMR 
probe design, high resolution spectra can be obtained and sophisticated pulse 
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sequences can be applied. At the same time, advanced computers and workstations are 
capable of controlling experiments and various powerful softwares make it easier and 
faster to analyze spectra. Furthermore, multidimensional multinuclear techniques have 
overcome the problem of overlap caused by the large number of protons in a protein. 
Last but not least, with the improvement of understanding of fundamental NMR 
parameters, new NMR experiments are to be designed and more accurate structural 
information can be obtained (Reid, 1997).  Both instrumental and methodological 
methods of NMR are in a continually evolving process and NMR will become even 
more powerful in protein structural and functional studies. 
When the first protein solution structure was solved at 1986 by Wüthrich 
(Wüthrich, 1986), the sequential resonance assignment was done using several 2D 
NMR experiments. Conventional sequential resonance assignment of small proteins 
relies on 2D COSY and TOCSY spectra to identify the residue type of each spin 
systems, and 2D 1H-1H NOE experiments to identify sequential connections along the 
backbone. Finally, comparison of the connected peptide information to known protein 
sequence will yield sequence-specific resonance assignment. With increasing protein 
molecular weight, 2D experiments are no longer sufficient to solve the problem of 
spectral complexity due to resonances overlap. This barrier can be overcame with 
multidimensional hetero-nuclear NMR techniques and uniformly 13C and 15N labeled 
proteins. Furthermore, applying deuteration technique to replace protons will 
dramatically reduce the line widths therefore facilitate the assignment of backbone 
and side chain carbon for proteins larger than 25kDa.  
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The introduction of 3D and 4D hetero-nuclear NMR experiments and the 
availability of uniformly 15N -13C labeled samples allow one to assign proton, 
nitrogen and carbon chemical shifts of proteins and protein complexes with molecular 
weight above 25 kDa and to determine their structures in solution (Clore and 
Gronenborn, 2000). Peak overlapping will be reduced evidently by using 
hetero-nuclear correlation experiments because of resonance spreading into an 
additional dimension. These experiments used are highly selective for correlations of 
three spins (1H, 13C, 15N), which significantly simplify the identification of atoms 
involved in correlations. Additionally, it places much less dependency on NOE 
connectivity, which may be ambiguous in larger proteins.  
The main source of geometric information used in protein structure 
determination lies in the nuclear Overhauser effect (NOE), which can be used to 
identify protons separated by less than 5Å. This distance limit arises from the fact that 
the NOE is proportional to the inverse-sixth power of the distance between protons. 
Hence, the NOE intensity falls off very rapidly with increasing distance between 
proton pairs. The nuclei involved in the NOE correlation can belong to amino acid 
residues that may be far apart along the protein sequence but close in space. Usually 
NOE intensities are converted into estimation of inter-proton distance restraints, for 
NOEs arising from protein molecules can’t be quantitatively interpreted due to spin 
diffusion and motional effects. 
The detailed analysis of protein spectra is based on through-bond and 
through-space correlations. Through-bond correlations group individual spins into 
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spin systems which are used for the analysis of the spectra. In proteins J couplings 
over more than three chemical bonds are usually too small to be observed. 
Consequently, only spin systems within individual amino acids can be obtained in 
proton spectrum. In proteins which are labeled with 15N and 13C, J couplings between 
1H, 15N and 13C allow through-bond correlations across the peptide bond. 
Through-space correlations provide the basis for geometric information required to 
determine the structure of a macromolecule and are measured via NOE. Although the 
panoply of 3D hetero-nuclear experiments is sufficient for the purposes of spectral 
assignment, further increases in resolution are required for the reliable identification 
of NOE through-space interactions. This can be achieved by extending the 
dimensionality still further to four dimensions.  
The general strategy for determining the structures of proteins by NMR is 
sequential resonance assignment, collection of conformational constraints and 
calculation of the 3D structure (Gerhard, 2000). First of all, an efficient structure 
determination by NMR requires a highly purified protein preparation. The 
macromolecule under study should be stable in the chosen conditions for many weeks. 
The inherent low sensitivity of the technique requires protein concentrations of about 
1mM. Due to the large number of protons in a protein, to reduce the problem of peak 
overlap it is necessary to do all panoply of multidimensional hetero-nuclear NMR 
experiments. Hence the uniform 15N- and 13C-labelling experiments have to be done. 
For large proteins deuteration and specific labeling are advantageous.  
Though chemical shift assignment by itself has no biological relevance, 
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sequence-specific resonance assignment is required in structural determination. The 
aim is to identify the chemical shift of each 1H, 13C and 15N nuclei individually in a 
protein. The resonance assignment forms the basis for extraction of conformational 
dependent parameters (Moseley, 1999). Complete or nearly complete resonance 
assignment is the prerequisite for further structural studies by NMR, such as 
characterization of secondary structure, determination of 3D structure, protein 
dynamics and protein-ligand interaction. 
For unlabelled small protein, the combination of two 2D spectra often allows 
complete assignment of most proton NMR signals. But for larger proteins extensive 
signal overlap prevents complete assignment of all proton signals. Hence, a variety of 
triple resonance experiments based on through-bond correlations across the 
peptide-bond between sequential amino acids are necessary to make sequential 
assignments. The mostly used spectra for sequential assignment are CBCA (CO) NH 
and HNCACB experiment, which are named after the specific coherence transfer 
pathway employed. Combining these two experiments, connections between residues 
can be made except proline which has no amide proton. Additionally, several specific 
amino acids with special chemical shift of Cα and Cβ can be identified. Finally when 
there is only one match between specific combination of amino acid obtained from 
spectra and primary sequence of protein, sequential assignment can be achieved. 
Similarly, HNCO and HN (CA) CO experiments serve the same purpose except that 
carbonyl carbon chemical shift is used as a connection instead of Cα and Cβ. In 
practice, these two set of spectra can be used complementally to solve ambiguities 
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caused by chemical shift degeneracy. After sequential assignment, other experiments 
like HCCH-TOCSY can proceed to gain side chain proton assignments.  
With the completion of sequential assignment, geometric conformational 
information in the form of distances and/or torsion angles has to be derived from the 
NMR data. Although a variety of NMR parameters contain structural information, the 
crucial information comes from NOE measurements which provide distance 
information between pairs of protons. For both 15N-NOESY-HSQC and 
13C-NOESY-HSQC, each cross peak reflects that the two protons are separated by a 
distance less than approximately 5.0Å. The intensity of NOE peak can be converted to 
approximate distance. Although resonance overlap in 3D spectrum is dramatically 
reduced compare to that in 2D, interpretation of 3D spectrum is not straightforward. 
Even if the chemical shift of each proton is known after the completion of sequential 
assignment, these chemical shifts are not unique enough to identify each proton. One 
way to solve the problem is to introduce a second hetero-nuclear dimension in doubly 
edit 4D NOESY experiment. However, these experiments are less sensitive than those 
3D ones, because of the additional hetero-nuclear dimension and longer pulse 
sequence. Whereas combination of 3D and 4D NOESY spectrum can provide almost 
unambiguous assignment of NOE cross peaks, which is especially important in the 
initial phase of NOE assignment.  
Supplementary constraints can be derived from through-bond correlations in 
the form of dihedral angels. Further, chemical shift data, especially from 13C, provides 
information on the type of secondary structure and hydrogen bonds can be derived by 
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measuring the protection of amide proton against chemical exchange using H/D 
chemical exchange experiments. The quality of a solution structure increases with the 
number of consistent input constraints used in the structure calculation. Especially, 
long-range NOEs are essential for protein tertiary structure.  
The two most common approaches for generation of structures employ 
distance geometry (DG) and restrained molecular dynamics. The term DG emphasizes 
the fact that the structure is derived using predominantly geometric criteria. While the 
second approach, restrained molecular dynamics, is based on classical mechanics and 
proceeds by numerically solving Newton’s equation of motion in order to calculate 
the three-dimensional structure of a protein. In practice, often a combination of DG 
and molecular dynamics is used to calculate the structure.  
High quality spectra with good sensitivity and resolution are the foundation of 
successful NMR structure studies of macromolecules. NMR has the ability to 
characterize the overall tumbling and internal dynamics of proteins. But in practice, it 
becomes very hard to determine structures from proteins that have molecular weights 
above 40 kDa. Important advances in extending this size limit have been made 
recently with the introduction of novel NMR techniques and new biochemical 
approaches. More importantly, relaxation in large molecules could be reduced with 
TROSY (transverse relaxation-optimized spectroscopy) method (Pervushin, 1997), 
also the potentially limiting problem of spectral crowding is addressed by biochemical 
methods. TROSY uses constructive interference between different relaxation 
mechanisms and works best at the highest available magnetic field strengths in the 
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range of 700 to 900 MHz proton resonance frequency. It enables the recording of high 
quality NMR spectra of macromolecules and supra molecular structures with 
molecular weights above 100kDa (Pervushin, 2000). It can be anticipated that many 
more NMR structures of larger proteins and protein complexes will become available 
by the widespread use of novel NMR experiments and creative isotope labeling 
schemes. In addition, development of higher magnetic fields and improvement of 
spectrometer hardware will result gains in resolution and sensitivity that will further 
increase the upper molecular weight limit for structural studies by NMR. 
An important use of three-dimensional structural information of proteins is to 
uncover clues as to a protein’s function that is not detectable from sequence analysis 
(Zarembinski, 1998). It has been demonstrated that structural proteomics, the 
determination of 3D protein structures on a genome-wide scale, is feasible and can 
play a central role in functional genomics. The discovery of completely new protein 
folds may not be a common occurrence, but that considerable biochemical insights 
can be gained either from the structures themselves or subsequent biochemical 
experiments suggested by the structures (Arrowsmith, 2000).  
In our study, protein ec314 is one protein in the set of 424 non-membrane 
proteins from Methanobacterium thermoautotrophicum. It is a novel protein with very 
low sequence similarity to other proteins and its function remains unknown. From the 
structural studies by NMR techniques, we hope to identify a novel structure or predict 
its function based on 3D structure. 
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1.3 Objective 
1.3.1 Objective of brain metabolites study 
a). To find out if there is significant difference between metabolites of 
different types of brain tumors.  
b). Quantitative studies of major brain metabolites of both human and mouse.  
c). Make it possible to do clinical diagnosis of brain tumors by NMR spectra 
of metabolites. 
1.3.2 Objective of NMR structural studies of protein ec314 
To determinate the three dimensional structure of protein ec314 by analyzing 
various kinds of two dimensional and three dimensional NMR spectroscopy.  
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2. NMR study of brain metabolites 
 
2.1 Materials and Methods 
2.1.1 Sample preparation 
Human brain tissues and brain tissues of mouse were obtained from National 
Neuroscience Institute (NNI) and kept at approximately -80℃. For the liquid-state 
NMR, samples were dissolved in D2O and centrifuged at 14,500 rpm for 30 minutes. 
0.5 ml of clear supernatant was taken for NMR experiments. 
 
2.1.2 NMR experiments 
All 2D NMR experiments were carried out on a Bruker AVANCE 500 MHz 
spectrometer equipped with pulse field gradients and a cryo-probe. Samples were 
contained in 5mm NMR tube and the experimental temperature was kept at 25℃. 1D 
proton NMR data acquired were processed and analyzed by xwinnmr version 3.1 
(Bruker, 2001). 2D data acquired were processed by nmrDraw suite (Delaglio, 1995) 
and analyzed by NMRView (Johnson, 1994)  
 
2.1.2.1 1D HRMAS 1HMRS experiment 
High-resolution magic-angle spinning proton MRS (HRMAS 1HMRS) 
experiments were carried out on a 400 MHz Bruker AVENCE NMR spectrometer 
using a HR-MAS probe and sample was in a 4 mm rotor. The experiments were done 
at room temperature. The spin rate was stabilized at 2.500 kHz. 32k points were 
collected over a spectral width of 8012 Hz covering 20.025 ppm.  
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2.1.2.2 2D 1H-13C HSQC experiment 
In the acquired proton dimension, 1024 complex points were collected over a 
spectral width of 8012 Hz while in 13C dimension, 512 increments covering a spectral 
width of 17610 Hz. The spectrum was zero-filled to a 1024×1024 matrix size. HSQC 
spectrum was used to identify the metabolites by both 1H and 13C chemical shift.  
 
2.1.2.3 2D 1H-1H COSY experiment 
COSY spectrum was also used for identification of brain metabolites. In t2, 
1024 complex points were collected while there are 512 points in t1, both covering a 
spectral width of 4595 Hz. The spectrum was also zero-filled to a 1024×1024 matrix 
size. 
 
2.1.3 Chemical shift database 
Chemical shift is the basis for the identification of brain metabolites. By using 
various 2D and 3D NMR experiments like HSQC, HSQC-TOCSY, COSY, HMBC 
(Hetero-nuclear Multiple Bond Correlation), both 1H and 13C chemical shifts of most 
metabolites that may be observed in human brain have been assigned by comparing 
the chemical shifts with the shifts in the single compound spectrum. (Wieland Willker, 
et al 1996) 
To obtain assignments of brain metabolites, the chemical shift table of 









Acetate  2CH3 24.6 1.91 
Alanine  2CH 51.5 3.79 
Alanine 3CH3 17.4 1.47 
Creatine CH2 55.0 3.93 
Creatine CH3 38.1 3.03 
Choline CH3 53.99 3.18 
Choline 1CH2 68.43 4.05 
Choline 2CH2 55.95 3.50 
Glutamine 2CH 55.4 3.71 
Glutamine 3CH2 28.1 2.15 
Glutamine 4CH2 32.0 2.46 
Glutamate 2CH 55.8 3.77 
Glutamate 3CH2 28.4 2.06 
Glutamate 4CH2 34.7 2.34 
Isoleucine 4CH3 15.8 1.00 
Isoleucine 5CH3 12.2 0.92 
Myo-inositol  CH 72.1 3.55 
Lactate 2CH 69.5 4.12 
Lactate 3CH3 21.3 1.32 
Leucine 2CH 55.3 3.75 
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Leucine 3CH2 41.0 1.71 
Leucine 4CH 25.3 1.71 
Leucine CH3 22.3 0.94 
Lysine 2CH 55.7 3.74 
Lysine 3CH2 31.2 1.89 
Lysine 4CH2 23.2 1.44 
Lysine 5CH2 27.3 1.70 
Lysine 6CH2 40.5 3.01 
NAA CH3 23.2 2.01 
Serine 2CH 57.4 3.83 
Serine 3CH2 61.6 3.96 
Tyrosine 5CH 131.8 7.19 
Tyrosine 6CH 116.8 6.89 
Valine 2CH 61.6 3.61 
Valine 3CH 30.3 2.27 
Valine CH3 17.8 0.98 
Table 2.1 Chemical shift table of metabolites 
 
2.1.4 Quantitative analysis of brain metabolites 
There are totally 20 brain samples submitted for quantitative analysis, 16 of 
them are from human brain, 4 of them are from mouse brain. To achieve quantitative 
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analysis of brain metabolites, HRMAS 1HMRS spectroscopy has been used. The 
major metabolites which we are interested in are lactate, choline, creatine, NAA, 
alanine and myo-inositol. TSP has been added as an internal reference. Chemical shift 
values are given relative to TSP at 0.0 ppm. Figure 2.1 is an example of HRMAS 
1HMRS spectrum of brain metabolites.  
 
 
Figure 2.1  HRMAS 1HMRS spectrum of brain metabolites 
 
  2.1.4.1 HRMAS 1HMRS  
The understanding of brain MR spectrum which relies on analysis of chemical 
extracts of tissue samples may introduce artifacts. However, direct proton MRS 
analysis of brain tissue may compromised by poor spectral resolution. Magic angel 
spinning (MAS) can reduce MR spectral line-widths. Applying MAS on 
human/animal tissue reduces the effect of residual molecular interaction and the 
influence of magnetic susceptibility on spectral broadening. It has been proved that 
HRMAS 1HMRS of unprocessed brain tissue can produce spectra of a quality 
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heretofore observed only with liquid samples of brain extracts (Cheng, 1997). 
Meanwhile it will bring no artifacts, hence HRMAS 1HMRS of brain may be ideal for 
elucidating in vivo MRS observation because it can produce high resolution spectra of 
unprocessed brain samples. 
 
2.1.4.2 Matlab program  
In theory, NMR spectroscopy can be used directly in quantitative analysis 
because of the direct proportionality of the integrated resonance intensity (I) and 
concentration (C) of nuclei giving the resonance: I=kC, where k is a constant (Leyden, 
1977). With proper attention to experimental conditions, the proportionality constant 
is the same for all resonances in a spectrum. Using NMR spectroscopy, relative 
concentrations can be obtained directly from relative resonance intensities while 
absolute concentrations can be obtained by adding a known concentration of another 
compound as an internal intensity standard.  
But in practice, due to the complexity of real samples, the spectra are very 
crowded and overlapped. Resonance at the same position may not come from only 
one compound. For example, in metabolites studies, a triplet of myo-inositol at 
3.27ppm is typically hidden under choline which has a singlet at the same chemical 
shift arise from the tri-methyl protons. Therefore, that peak at 3.27 ppm contains 
signals from both myo-inositol and choline. The intensity of peak can represent the 
quantity of neither compound. As a consequence, peak heights cannot be used directly 
to calculate the concentration of the compound.  
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To overcome this problem, our solution is using Matlab program to separate 
signals from different metabolites and then gain absolute peak height of individual 
metabolite. The peak height gained through Matlab program therefore can represent 
the concentration of the compound because the simulated curve is assumed to derive 
from only one compound.  
To apply the Matlab program to analyze experimental data, a number of 
parameters are needed, such as start point and end point of HRMAS 1HMR spectrum, 
the total points. The detailed experimental data was transferred into text file and 
inputted into the Matlab at the beginning. After that, there are three parameters have 
to be adjusted. First, ppeak, which represents peak position in ppm, is given by 
peak-picking in data processing. Second, wpeak, which represents peak line-width in 
ppm, vary with compounds. Usually peak line-width only depends on the compound 
itself and will be slightly different when under different circumstance. In our study, 
the experimental environment of each sample is almost the same. Therefore the peak 
line-width is same for each compound in different samples. Third, hpeak, which 
represents exact peak height of interested compound, is the most important parameter 








SWs=SWs; % start point in ppm 
SWe=SWe; % end point in ppm 





    m1=floor((SWs+0.2)*SI/(SWs-SWe)+1); 





























AXIS([dp(1) dp(1000) minI/maxI*100-1 101]); 
 
Figure 2.2 Matlab program 
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Most brain metabolites contain singlet 1HNMR signals (Govindaraju, 2000). 
For such compound, there is only one peak picked which means only ppeak1, wpeak1 
and hpeak1 values needed for running Matlab program. The red lines and blue lines in 
the program will be skipped. Upon that, one singlet from the metabolite and one curve 
from other components will be presented. For those metabolites have doublet, there 
are two picked peak position values gained. Therefore the red lines in the program are 
also needed when doing curve simulation. As a result, a doublet will be presented. If 
there are completely no signals from other metabolites hidden under the peak which is 
under simulation, the fitted curve then will match the experimental one.  
 
2.1.4.3 Curve fitting and calculating 
Input the experimental data in Matlab program and adjust the values of ppeak, 
wpeak and hpeak, until curve is fitted. Figure 2.3 shows the results. Figure A is fitted 
curve of Lactate. The blue line represents the original curve from experimental data. It 
can tell, from the shape of curve, that there are signals from other compounds hidden 
under it. It may come from threonine which has a doublet also at 1.32 ppm arise from 
CH3 protons coupling with the CH proton. Furthermore, this spectral region is also 
frequently complicated by the presence of lipid resonances. After simulation, one 
sharp green doublet is presented which represents the exact curve of lactate. Last one, 
the red curve comes from other compounds. Obviously using Matlab program 
different compounds which have peaks at same chemical shift can be separated. 
Figure B shows the fitted curve of TSP which has a singlet at chemical shift 0 ppm. 
Since there is no other compounds presented at this region, the fitted curve is 
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consistent with the experimental one as mentioned above. 
A  Fitted curve of Lactate at 1.32 ppm        B  Fitted curve of TSP at 0 ppm 
 
o calculate the concentration of compounds, 5 µl of 10-2 M TSP is added as 
an internal reference. According to I=kC, the peak intensity is proportional to proton 
number times concentration. Relative peak intensity can be obtained by Matlab 
program; proton numbers and amount of TSP are already known. Hence the absolute 
amount of the metabolites can be calculated using the following equation. Table 2.2 
shows the structure formula and total proton numbers of specific groups (highlighted 
in red Bold) of both TSP and major metabolites. 
Equation:  

















Compound Structure formula Proton number 































































2.2 Results and Discussion 
2.2.1 Identification of brain metabolites 
To obtain identification of brain metabolites and discover the significant 
differences between different types of brain tumors, two samples from different 
human brain tumor have been submitted to do NMR experiments. For both samples, 
2D 1H-13C HSQC and COSY spectra have been obtained.  
Only the correlation between protons attached to adjacent carbons can be seen 
on a COSY spectrum, which provides direct connectivity between different groups in 
a compound. For example, the cross peak in the COSY spectrum of sample NNI1 
shown in Figure 2.4A at (3.70ppm, 1.39ppm) represents alanine, 3.70ppm 
corresponding to CH proton while 1.39ppm corresponding to CH3 protons. Based on 
the correlations and proton chemical shifts provided by the COSY spectrum, major 
metabolites can be identified. On the other hand, an HSQC spectrum can provide both 
1H and 13C chemical shifts of metabolites. With the chemical shift database of 
metabolites and the correlations between protons provided by the COSY spectrum, 
almost all of the metabolites shown in the HSQC spectrum of human brain can be 
assigned. 
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 Figure 2.4A  COSY spectrum of human brain tissue sample NNI1  
 
In the HSQC spectrum of sample NNI1 shown in Figure 2.4B, there are totally 
four valine peaks can be identified. Two peaks which have 13C chemical shift 20.27 
and 18.97 ppm and 1H chemical shift 0.95 and 0.90 ppm respectively are arise from 
the two methyl groups of valine. Another peak at chemical shift (62.84ppm, 3.51ppm) 
is corresponding to the CHα group. The fourth peak at chemical shift (31.45ppm, 
2.18ppm) is corresponding to CHβ group. The COSY spectrum shows two cross peaks 
at 1H 2.19-0.91 ppm and 2.19-0.95 ppm, correlates the two methyl group protons to β 
proton respectively. For lactate, there are two peaks at (70.91ppm, 4.02ppm) and 
(22.40ppm, 1.24ppm) arise from CH and CH3 group respectively and there is a cross 
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peak at (4.03ppm, 1.24ppm) correlates methyl proton to methine proton on the COSY 
spectrum. Similarly, leucine has four peaks with two methyl group at the same 
position and isoleucine has five peaks, both of them have cross peaks correlate the 
methyl protons to methine proton on the COSY spectrum.  
There is one prominent peak at 13C chemical shift 25.63ppm and 1H 1.83ppm 
represented acetate which has especially high peak intensity. In addition, beyond 13C 
chemical shift 100ppm and 1H chemical shift 6ppm, there are three peaks represent 
tyrosine and proline separately. On the COSY spectrum, there is one peak at 1H 
6.82-7.13ppm correlates the protons of tyrosine.  
Combining the COSY and HSQC spectra and using chemical shift database as 
a reference, the metabolites in sample NNI1 were assigned. There are isoleucine, 
valine, leucine, alanine, lactate, lysine, acetate, glutamate/glutamine, creatine, choline, 
tyrosine, threonine and γ-aminobutyric acid in the sample NNI1. 
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 Figure 2.4 B  HSQC spectrum of human brain tissue sample NNI1 
Acetate (Ac), alanine (Al), choline (Cho), creatine (Cr), glutamate/glutamine 
(Glx), isoleucine (I), leucine (L), lactate (Lac), lysine (Ly), threonine (Th), 
tyrosine (Ty), valine (V) and γ-aminobutyric acid (GABA). 
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Combining the HSQC and COSY spectra, the brain metabolites of sample 
NNI2 can be assigned. Similarly there are isoleucine, valine, leucine, alanine, lactate, 
lysine, glutamate/glutamine, creatine, choline, threonine, and γ-aminobutyric acid in 
the sample NNI2. There are one prominent peak at 13C chemical shift 25.02 ppm and 
1H chemical shift 1.97 ppm which has similar peak intensity to the strong peak in 
NNI1. However it represents N-Acetylaspartate. Usually, NAA has a singlet from the 
three protons of an N-acetyl CH3 group which chemical shift is 0.1 ppm larger than 
the methyl protons of acetate. Compared the two HSQC spectra of samples, we can 
tell that the strong peak in NNI1 is from acetate, while in NNI2 it is from NAA. 
Unlike the HSQC spectrum of NNI1, there is no signal in the region 13C chemical 
shift beyond 100ppm and 1H chemical shift beyond 6ppm on the HSQC spectrum of 
sample NNI2 which means there is no tyrosine in it. The HSQC spectrum of sample 
NNI2 shown in Figure 2.5B has a very crowded region of 13C chemical shift from 
65ppm to 80ppm and 1H chemical shift from 3.4ppm to 4.0ppm, it is mainly due to 
the presence of mono-sacchride, glycogen. Glycogen shows 5 pairs of peaks in HSQC 
spectrum, each pair of peaks have the same 13C chemical shift and different 1H 
chemical shift. All the peaks are present in the region mentioned above. In addition, 
myo-inositol presents near this region. It gives four groups of resonances. The 1H 
chemical shifts vary from 3.4 ppm to 4.1 ppm and 13C chemical shift from 72ppm to 
78 ppm. As a conclusion, sample NNI2 contains isoleucine, valine, leucine, alanine, 
lactate, lysine, N-Acetylaspartate, glutamate/glutamine, creatine, choline, threonine, 
myo-inositol, mono-sacchride and γ-aminobutyric acid. 
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 Figure 2.5A  COSY spectrum of human brain tissue sample NNI2 
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 Figure 2.5 B  HSQC spectrum of human brain tissue sample NNI2  
Alanine (Al), choline (Cho), creatine (Cr), glutamate/glutamine (Glx), isoleucine 
(I), leucine (L), lactate (Lac), lysine (Ly), N-Acetylaspartate (NAA), threonine 
(Th), valine (V), myo-inositol, mono-sacchride and γ-aminobutyric acid (GABA). 
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There are three major differences between two samples. First, NNI1 contains 
acetate at (25.63ppm, 1.83ppm) while NNI2 contains NAA at (25.02ppm, 1.97ppm) 
as shown in the HSQC spectra. Previous studies pointed out that the increase in 
acetate is mostly due to the degradation of NAA, though it may also be produced by 
other neuron-chemical degradation processes. The decrease of NAA may indicate 
neuron loss and high level of acetate which is an essential building block for synthesis 
of a number of compounds may imply loss of synthetically ability.  
Second, mono-saccharide exists in sample NNI2 which causes the crowded 
region in the HSQC spectrum as mentioned above, and also myo-inositol while there 
is no signal at the same region in sample NNI1. The mono-saccharide is a source of 
energy and myo-inositol is an essential requirement for cell growth and a storage form 
for mono-sacchride. Lack of these two compounds may indicate loss of energy and 
activity in brain. All these facts, loss of NAA, presence of acetate and absence of 
mono-sacchride and myo-inositol of sample NNI1, indicate that the major activities 
and primary functions of the brain have been damaged.  
Third, NNI1 contains tyrosine while NNI2 does not. Tyrosine is an essential 
neutral amino acid and a precursor of the neurotransmitters epinephrine, 
nor-epinephrine and dopamine. The presence of tyrosine in sample NNI1 may come 
from oral consumption and hepatic encephalopathy. 
Though there are many significant differences in brain metabolites observed 
between these two different brain tumor samples, it is not sufficient to do clinical 
diagnosis only from the NMR data of the metabolites. The direct correlation between 
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brain tumor and metabolites is still not well-known. Nonetheless, NMR technique was 
proved to be an effective and straightforward tool for differentiating between brain 
tumors by analyzing its metabolites. When the NMR study of metabolites goes further, 
large numbers of brain samples will be studied. Therefore, the unique characteristic of 
brain metabolites related to different types of brain tumors may be discovered. As a 
consequence, the NMR spectroscopy of brain metabolites will become a new and 
strong evidence for early detection and diagnosis of brain diseases.  
Traditionally, only 1D 1H NMR was applied in clinical researches because it’s 
rapid and very easy to apply due to its extreme simple pulse sequence. However, the 
complexity of the biological samples and the limitation of 1D NMR make it difficult 
to assign each metabolite clearly. Usually, 1D proton NMR of biological samples has 
a problem of overlap and become very crowded in methyl region from 0.9-1.05ppm. 
It is impossible to assign each peak in that region separately. Furthermore, some 
metabolites have peaks in the same position which makes assignment very 
complicated and time-consuming. For example, the myo-inositol has a triplet at 
3.27ppm which typically hidden under choline and lactate has a doublet at 1.31 ppm 
in a very complicated region by the presence of lipid resonances. Typically, there is 
only one characteristic peak can be assigned for each compound which obviously 
brings uncertainty of assignment.  
Applying 2D NMR experiments, these problems will be solved. Firstly, 2D 
HSQC spectrum allows us assign both 1H and 13C resonances of metabolites which 
will reduce the uncertainty of assignment and solve the problem of overlap. It is very 
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seldom that both 1H and 13C chemical shift are the same for different compounds. 
Therefore, those peaks with same 1H chemical shift can be separated by different 13C 
chemical shifts and make it possible to assign every group of compound individually. 
Secondly, COSY spectrum provides the correlation of the protons in a compound 
which confirms assignment doubly. Moreover, these 2D experiments also have simple 
pulse sequence and can be done in a short time. They provide more information on 
structure and very convenient, thus making assignment faster and more precise. 
Spread the application of 2D NMR techniques in clinical research will accelerate the 
metabolites’ studies. Furthermore, the invention of new quantitative analytical method 
using 2D NMR spectra will contribute a great deal to make it possible to detect and 
diagnose brain diseases by analyzing NMR spectra of its metabolites.  
 
2.2.2 Quantitative analysis of metabolites 
Fitting the HRMAS 1HMRS spectrum with the Matlab program, we estimated 
the absolute amount of major metabolites in different brain tumor sample. The 
calculated metabolites were lactate (1.32ppm, 1.34ppm, doublet), NAA (2.02ppm), 
creatine (3.04ppm), choline (3.27ppm), alanine (3.78ppm), glycine (3.55ppm) and 
myo-inositol (3.60ppm).  
Table 2.3a lists the absolute amount of metabolites of 4 mouse brain samples. 
Table 2.3b, Table 2.3c, Table 2.3d list the absolute amount of metabolites of human 
brain samples. They are submitted by three times. The first set of 3 human brain 
samples were submitted on 27th March, the second set of 4 samples on 31st March and 
the final set of 9 samples on 19th May.  
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Sample NO. NNI_M1 NNI_M2 NNI_M3 NNI_M 
TSP 5 5 5 5 
Lactate 150 48.59 74.25 28.75 
NAA 45 30 37.5 7.5 
Creatine 75 32.14 38.5 15 
Choline 35 35.71 40 11.67 
Alanine 56.25 25.71 45 15 
Glycine - 19.28 22.5 5.63 
Myo-inositol 22.5 9.64 15 - 
Table 2.3a  Amount of metabolites of mouse brain tissues (10-8 mmol) 
 
Sample NO. MA27_H1 MA27_H2 MA27_H3 
TSP 5 5 5 
Lactate 69.87 121.05 139.34 
NAA 15.79 9 26.67 
Creatine - 15 73.33 
Choline 5.26 10 28.89 
Alanine - 45 50 
Glycine - 18 30 
Myo-inositol - 26 30 
Table 2.3b  Amount of metabolites of human brain tissues (10-8 mmol) 
submitted on 27th March 
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Sample NO. MA31_H1 MA31_H2 MA31_H3 MA31_H4 
TSP 5 5 5 5 
Lactate 9.87 211.87 73.34 33.15 
NAA 3 107.14 5 97.5 
Creatine - 26.78 5 6 
Choline 0.6 8.93 5.55 1.5 
Alanine 13.5 - 5.55 - 
Glycine - 20.09 12.5 - 
Myo-inositol - - - - 
Table 2.3c Amount of metabolites of human brain tissues (10-8 mmol) submitted 
on 31st March 
 
Sample NO. MAY_H1 MAY_H2 MAY_H3 MAY_H4 MAY_H5
TSP 5 5 5 5 5 
Lactate 51.58 37.56 28.16 285.7 36.22 
NAA 18.37 2.61 - 357.14 16.15 
Creatine 6.12 5.22 3.36 57.14 9.23 
Choline 6.12 8.7 - 50 3.08 
Alanine 22.96 19.57 8.27 600 34.62 
Glycine 11.48 5.87 4.59 30 7.79 
Myo-inositol - - 3.21 - - 
Table 2.3d  Amount of metabolites of human brain tissues (10-8 mmol) 
submitted on 19th May 
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Sample NO. MAY_H6 MAY_H7 MAY_H8 MAY_H9 
TSP 5 5 5 5 
Lactate 239 40.28 28.42 63 
NAA 16 - 3.33 14.21 
Creatine 25 8.04 3.33 18.94 
Choline 36.67 3.21 3.33 11.58 
Alanine 210 16.07 15 18.94 
Glycine 60 7.23 5 9.47 
Myo-inositol 30 8.04 - 9.47 
Table 2.3d  Amount of metabolites of human brain tissues (10-8 mmol) 














2.3 Conclusion  
In Combination of 2D HSQC and COSY spectra, the brain metabolites can be 
assigned. Significant differences in metabolites were observed between different brain 
tumors. With sufficient samples of brain tumors being studied, the knowledge of the 
correlation between brain tumor and its metabolites will be highly improved. Thus it 
will become possible to differentiate brain tumors by analyzing its metabolites using 
NMR spectroscopy. Furthermore, the quantity of brain metabolites can be calculated 
using HRMAS 1HMR spectra. It can give us more information on concentration 
changes of metabolites. Most importantly, it permits an understanding of the 
diagnostic information provided by in vivo MR spectroscopy, and thus can guide the 
development of highly specific medical imaging methods. Based on these facts, NMR 
shows that it’s suitable as a tool for clinical and experimental neuron-pathologic 
investigations.  
 44
3. NMR structural studies on protein ec314 
3.1 Materials and Methods 
3.1.1 NMR experiments 
The target gene was cloned into an Escherichia coli expression vector 
containing an N-terminal hexa-His tag followed by a thrombin cleavage site and 
expressed in E. coli BL21-Gold (DE3) cells. The protein was then purified by 
Ni-NTA affinity chromatography and further purified by ion exchange 
chromatography after removal of the HIS tag. It was dialyzed and concentrated in 50 
mM phosphate buffer (pH 6.5) containing 50 mM 1,4-dithiolthreitol, and 3 mM 
sodium azide. 0.5 mM uniformly 15N, 13C labeled protein (molecular weight around 
7kDa) was used for NMR studies.  
All NMR experiments were carried out on a Bruker AVANCE 500MHz 
spectrometer equipped with pulse field gradients and a cryo-probe. The experimental 
temperature was 25℃. Data acquired was processed by NMRPipe/NMRDraw suite 
(Delaglio, 1995) and analyzed by NMRView (Johnson, 1994).  
3.1.1.1 2D 1H-15N HSQC spectrum 
In the amide proton dimension, 1024 complex points were collected over a 
spectral width of 8012 Hz. 200 increments were acquired in the 15N dimension, 
covering spectral width of 1600 Hz. A total of 4 transients were recorded per 
increment and the 15N carrier frequency was placed at 116 ppm. The spectra were 
zero-filled to 2048×512 matrix size. 
3.1.1.2 HNCACB and CBCA (CO) NH 
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This type of triple-resonance experiments which were used to make sequential 
assignment usually have a name related with the specific coherence transfer pathway 
employed. For example, coherence transfer pathways employed in CBCA(CO)NH 
and HNCACB experiments are shown in Figure 3.1. 
 1HNi – 15Ni – 13Cαi-1/ 13Cβi-1                            1HNi – 15Ni – 13Cαi/ 13Cβi 
1HNi – 15Ni – 13Cαi-1/ 13Cβi-1
Figure 3.1  Schematic show of coherence transfer pathways employed and the correlations made 
in CBCA(CO)NH and HNCACB experiments.  
(Referring to http://www.cryst.bbk.ac.uk) 
The CBCA(CO)NH experiment correlates the 1HN and 15N resonance of each 
residue with the aliphatic Cα and Cβ resonances of its preceding residues (Grzesiek, 
1993A). In the acquired proton dimension (F3), 1024 complex points were acquired 
over spectral width 8012.8 Hz. In the 15N dimension (F2), 30 complex points were 
acquired over spectral width 1013.9Hz. 51 complex points were acquired in the 13C 
dimension (F1) over a spectral width 7700 Hz covering 61 ppm. The 13C and 15N 
carrier frequency were placed at 43ppm and 118 ppm respectively. States-TPPI 
quadrature detection was used in F1 dimension and Echo/Antiecho gradient selection 
in F2dimension. The spectrum was linear predicted in both 13C and 15N dimensions 
and zero-filled to a 2048×128×256 matrix. A sine bell function was applied to 
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amide proton dimension and a sine bell squared function was applied to both 13C and 
15N dimensions.  
The HNCACB experiment correlates the 1HN and 15N resonance of each 
residue with the aliphatic resonances of the same residue (Witterkind, 1993). This 
experiment may also provide inter-residue correlation. There may be four cross peaks 
for each residue connects the chemical shifts of 1HNi and 15Ni with the chemical shift 
of Cαi, Cβi and Cαi-1, Cβi-1. In the proton dimension (F3), 1024 complex points were 
acquired over spectral width 8012.8 Hz. In the 15N dimension (F2), 52 complex points 
were acquired over spectral width 1013.9Hz. 102 complex points were acquired in the 
13C dimension (F1) over a spectral width 7700 Hz covering 61 ppm. The 13C and 15N 
carrier frequency were placed at 43ppm and 118 ppm respectively. States-TPPI 
quadrature detection was used in F1 dimension and Echo/Antiecho gradient selection 
in F2 dimension. The spectrum was linear predicted in both 13C and 15N dimensions 
and zero-filled to a 2048×128×256 matrix. A sine bell function was applied to 
amide proton dimension and a sine bell squared function was applied to both 13C and 
15N dimensions.  
Combining these two 3D experiments, connection among residues can be 
obtained except proline which has no amide proton. In addition, for medium-sized 
proteins, HNCO and HN(CA)CO experiments which provide carbonyl carbon 
chemical shifts will be used to make sequential assignment.  
3.1.1.3 C (CO) NH and H (CCO) NH 
For C(CO)NH experiment (Grzesiek, 1993B), 1024 complex points were 
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acquired over spectral width 8012.8 Hz in the proton dimension (F3), while 30 
complex points were acquired over spectral width 1013.9 Hz in the 15N dimension 
(F2). In the 13C dimension (F1), 102 complex points were acquired over spectral 
width 7700 Hz coving 61 ppm. The 13C and 15N carrier frequency were placed at 
43ppm and 118 ppm respectively. States-TPPI quadrature detection was used in F1 
dimension and Echo/Antiecho gradient selection in F2 dimension. The spectrum was 
linear predicted in both 13C and 15N dimensions and zero-filled to a 2048×128×256 
matrix. A sine bell function was applied to amide proton dimension and a sine bell 
squared function was applied to the other two dimensions. 
For H(CCO)NH experiment (Montelione, 1992), 62 complex points were 
acquired in 15N dimension (F2) over spectral width 1216.5Hz while 1024 complex 
points were acquired in proton dimension (F3) of amide proton over spectral width 
8012.8 Hz. 120 complex points were acquired in the indirectly recorded proton 
dimension (F1) over spectral width 3000Hz covering 5.97ppm. The carrier 
frequencies of these two dimensions are 118 ppm and 4.76 ppm respectively. 
States-TPPI quadrature detection was used in F1 dimension and Echo/Antiecho 
gradient selection in F2 dimension. Spectrum was linear predicted in 15N and the 
indirectly recorded proton dimensions and zero-filled to 2048×128×256 points. A sine 
bell function was applied to amide proton dimension and a sine bell squared function 
was applied to the other two dimensions. 
C(CO)NH experiment correlates 1HN and 15N resonance of one residue with 
the aliphatic Cα and Cβ resonances of its preceding residue, while H(CCO)NH 
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experiment correlates HN and N resonance of one residue with the aliphatic Hα and Hβ 
resonances of its preceding residue. 
3.1.1.4 HCCH-TOCSY 
HCCH –TOCSY experiment was used to assign aliphatic 1H, 13C spin systems 
by linking them to the backbone resonances (Kay, 1993). In a HiCi-…-HjCj-spin 
system a 3D HCCH –TOCSY experiment connects chemical shifts Hi, Hj and Cj. 
1024 complex points were acquired in the directly detected proton dimension 
(F3) over a spectral width 8012.8Hz. 64 complex points were acquired in the 
indirectly detected proton dimension (F1) over spectral width 3000Hz covering 
5.95ppm. 102 complex points were acquired in the 13C dimension (F2) with a spectral 
width 7700Hz covering 61ppm. The carrier frequencies for both proton dimensions 
were set to 4.76ppm. The carrier frequency of 13C dimension was placed at 39.0ppm.  
3.1.1.5 15N edited NOESY and 13C edited NOESY 
15N edited NOESY experiment provides NOE correlations between amide 
protons and other protons within a distance about 5Å (Zhang, 1994) while 13C edited 
NOESY experiment provides NOE correlation between 13C attached proton in both 
aliphatic and aromatic side chain. Usually the two experiments will be done separately, 
whereas in our study, both two types of NOE correlations were recorded in one 
spectrum named NOESYCN. Simultaneous evolution of 13C and 15N chemical shift 
was recorded in t2. The spectrum was divided into two parts and processed separately. 
The part with 1H chemical shift below 5 ppm in F3 dimension is equivalent to the 13C 
edited NOESY spectrum, and the part with 1H chemical shift beyond 5 ppm in F3 
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dimension is equivalent to the 15N edited NOESY spectrum.  
In the part with 1H chemical shift beyond 5 ppm in F3 dimension, 768 
complex points were acquired in the amide proton dimension (F3) over a spectral 
width 5482.5Hz. 128 complex points were acquired in the indirectly detected proton 
dimension over spectral width of 5000Hz covering 9.95 ppm. 64 complex points were 
acquired in the 15N dimension with a spectral width of 1226.3Hz to cover 20ppm. The 
carrier frequency of 15N dimension is 118ppm.  
In the part with 1H chemical shift below 5 ppm in F3 dimension, 1024 
complex points were acquired in the directly detected proton dimension (F3) over a 
spectral width 8012.8Hz. 128 complex points were acquired in the indirectly detected 
proton dimension over spectral width of 5000Hz covering 9.95ppm. 102 complex 
points were acquired in the 13C dimension with a spectral width of 7700Hz to cover 
60.9ppm. The carrier frequency of 13C dimension is 43ppm. States-TPPI quadrature 
detection was used in F3 dimension and Echo/Antiecho-TPPI gradient selection was 
used in both F2 dimensions. Spectrum was linear predicted in 13C and 15N dimension 
and zero-filled to 1024×256×256 points. A sine bell function was applied to two 
proton dimensions while a sine bell squared function was applied to F2 dimension. 
Finally the F1-F3 projection of the NOESYCN spectrum was shown in Figure 
3.2. Only 13C chemical shift was shown in the 3D spectrum. Hereby a small TCL 
script (shown in Figure 3.3) was used to convert 13C chemical shift to 15N chemical 
shift.  
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 Figure 3.2  Overlook of NOESYCN spectrum (13C chemical shift 19.6-22.6 ppm) 
global Cref Cwid 
global Nref Nwid 
set Cref 43.0         % Carrier frequency of 13C dimension 
set Cwid 60.914      % Width of 13C dimension 
set Nref 118.0        % Carrier frequency of 15N dimension 
set Nwid 20.0        % Width of 15N dimension 
 
proc c2n { value } { 
global Cref Cwid 
global Nref Nwid 
set ratio [expr $Nwid/$Cwid] 




proc n2c { value } { 
global Cref Cwid 
global Nref Nwid 
set ratio2 [expr $Cwid/$Nwid] 
set re2 [expr {$ratio2*($value-$Nref)+$Cref}] 
return $re2 
} 
Figure 3.3  TCL script for conversion between 13C and 15N chemical shifts 
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3.1.2 Chemical shift assignment 
3.1.2.1 Backbone sequential assignment 
Using cross peaks in the 2D 1H-15N HSQC spectrum as reference, all cross 
peaks in CBCA(CO)NH and HNCACB spectra are grouped to clusters according to 
their 1H and 15N chemical shifts and are numbered. The 1H and 15N chemical shifts 
can be correlated with the corresponding Cα and Cβ chemical shift values for the same 
residue with the HNCACB spectrum and the preceding residue with the 
CBCA(CO)NH spectrum. Based on the Cα and Cβ chemical shift information, clusters 
can be connected to several small fragments containing a certain number of residues. 
Additionally, four types of amino acid residues (Ala, Thr, Ser, Gly) which have 
characteristic Cα and/or Cβ chemical shifts can be identified. Finally, sequential 
assignment can be obtained by mapping the fragments containing characteristic amino 
acid residues into the primary sequence of protein by matching the positions of those 
characteristic residues.  
 
3.1.2.2 Aliphatic side chain assignment 
After cross peaks in the HSQC spectrum have been assigned to specific 
residues, the side chain 1H and 13C chemical shifts of each residue can be assigned 
then by combining C(CO)NH, H(CCO)NH and HCCH-TOCSY spectra. C(CO)NH 
and H(CCO)NH spectra provide carbon and proton chemical shifts respectively, while 




3.1.3 Secondary structure  
3.1.3.1 Chemical shift index prediction 
The chemical shift of a nuclear spin at protein backbone depends on the nature 
of the amino acid and the secondary structure that the spin is located in. For each 
particular amino acid residue in a protein, both 1H and 13C chemical shifts of 
backbone nuclei are correlated with the secondary structure. In this case, the 
differences between Cα and Cβ chemical shift values from their random coil values are 
used to predict the type of secondary structure. Random coil values derived from 
model G-G-X-A-G-G were used as reference (Wishart, 1995).  
 
3.1.3.2 Sequential NOE pattern and short, medium-range NOE analysis 
The analysis of NOE including short- and medium-range NOE from 
15N-edited NOESY and 13C-edited NOESY will give an insight into the secondary 
structures of the protein. Stretches of dNN(i,i+1), dαN(i,i+3), dαβ(i,i+3) and dαN(i,i+4) 
connections are characteristics of α-helical regions. Stretches of strong dαN(i,i+1) 
connectivity are characteristic of extended strand. 
 
3.1.4 NOE assignment of 15N edited NOESY and 13C edited NOESY  
Based on the chemical shift assignment and secondary structure information, 
most of cross peaks from the 15N-edited part of NOESY can be unambiguously 
assigned. For the 13C-edited part of NOESY, the symmetry of cross peaks helps 
greatly on the assignment. Those long-range CH3-CH3 NOEs which have symmetrical 
peaks can be unambiguously assigned before the initial structure is calculated. At the 
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beginning, the initial structure is calculated on the basis of unambiguous NOEs. 
Afterwards, use the initial structure as a reference to further assign more NOE peaks. 
 
 3.1.5 Structure calculation 
  3.1.5.1 NOE restraints 
At the initial stage of structure calculation, NOE distant restraints have been 
generated by manually assigned NOE cross peaks from 15N part of NOESY and some 
unambiguous assigned 13C NOESY cross peaks. According to the peak volume, the 
distance upper bounds of the restraints have been calibrated to three categories (2.8, 
3.4, 5.0 Å). The NOE distant restraints were calibrated by automated structure based 
method during the automatic assignment stage by CYANA (Herrmann, 2002).  
 
  3.1.5.2 Dihedral angle restraints 
Dihedral angle restraints are generated by TALOS (Cornilescu, 1999). TALOS 
is a database system for empirical prediction of phi and psi backbone torsion angles 
using a combination of five kinds (HA, CA, CB, CO, N) of chemical shifts for a given 
protein sequence. The TALOS approach is an extension of the well-known 
observation that many kinds of secondary chemical shifts (i.e. differences between 
chemical shifts and their corresponding random coil values) are highly correlated with 
aspects of protein secondary structure. The goal of TALOS is to make quantitative 
predictions for the protein backbone angles phi and psi, and to provide a measure of 
the uncertainties in these predictions. In practice, TALOS uses data for three 
consecutive residues simultaneously including the information from the next and 
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previous residues as well as the given residue (i.e. 15 total secondary shifts and 3 
residue types) to make predictions for the central residue in a triplet.  
 
  3.1.5.3 Hydrogen bond restraints 
The formation of hydrogen bonds between backbone carbonyl oxygen and 
amide proton is also a characteristic of regular secondary structures. In the α–helix 
region hydrogen bond occurs between COi-NHi,i+4 and in β–sheets a dense network of 
hydrogen bond occurs between NH and CO from adjacent strands (Dempsey, 1986; 
Torchia, 1989). The hydrogen bond constraint is usually specified as a range of 
distances between the hydrogen donor and acceptor atoms (1.8-2.1). Linearity of the 
hydrogen bond may also be promoted by using a constraint between the acceptor and 
donor heavy atoms (2.7-3.0) for backbone N and O atoms. 
Use only those hydrogen bonds that can be integrated into the well-defined 
secondary structure regions to set restraints, the distance restraints are set for each 
hydrogen bond: HN-O (1.8-2.2 Å) and N-O (2.2-3.3 Å) respectively. 
 
  3.1.5.4 Structure calculation 
The software CYANA (Güntert, 2002) is used for structure calculation. At the 
initial stage of structure calculation, unambiguous NOE distance constraints, dihedral 
angle constraints and hydrogen bond constraints were used to get an ensemble of 10 
converged structures without distance violation above 0.5 Å and angle violation above 
5°. These 10 converged structures were then used as initial structure ensemble for 
automatic NOE assignment by CANDID/CYANA (Herrmann 2002). Then the 
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obtained NOE assignment was checked manually and fine tuned. One hundred 
structures are calculated by CYANA using the standard TAD protocol and restraints 
including NOE distance constraints, dihedral angle constraints and hydrogen bond 
constraints. Twenty structures with the lowest target functions are selected to 
represent the structure of ec314 and the average structure is used for display of the 
structure.  
The software MOLMOL (Koradi 1996) is used to display the structures and 
for the measurement of the structure statistics. Ramachandran plot analysis and NOE 
pattern plot are obtained using commands provided by CYANA and displaying in 
software Adobe Framemaker 7.1.  
 
3.2 Results 
3.2.1 Backbone assignment and aliphatic side chain assignment 
 3.2.1.1 Backbone assignment  
Firstly, here shows the sequence of protein ec314. It contains 72 residues.  
MLIPWQDLSPETLENLIESF VLREGTDYGEHERTLEQKVA 
DVKRQLQCGEAVLVWSELHE TVNIMPRSQFRE 
Combining CBCA(CO)NH and HNCACB spectra, most of the spin systems 
were connected together to several fragments based on tandem Cα and Cβ chemical 
shift values of residues. Figure 3.4 is the part of the assignment result from residue 
E24 to residue G29. 
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Figure 3.4  CACB connectivity from CBCA(CO)NH (①) and HNCACB (②) 
for a stretch of residues from E24 to G29  
 
Except for three prolines, there are four residues were unassigned, M1, V54, 
E57 and E60, due to absence of signals of their Cα and Cβ atoms. Due to the existence 
of HIS tag at the N-terminal, not all amino acids have been listed on sequence of the 
protein. The spectra also show those residues from the HIS tag. Therefore 11 peaks in 
HSQC spectrum were unassigned. Though this brought ambiguities and complexities 
in backbone assignment and increased the time of assignment, it will not affect the 
structural determination later on because it is Random Coil and gives no 3D structural 
information. As a result, nearly complete backbone assignment has been achieved for 
the protein. Figure 3.5 shows the sequentially assigned amide protons as labeled on 




Figure 3.5  The 1H-15N HSQC spectrum of 15N labeled ec314 
The backbone assignments are indicated as labels next to amide peaks.  
 
 58
  3.2.1.2 Aliphatic side chain assignment 
After sequentially backbone assignments, based on the known 1H and 15N 
chemical shift values of each residue, the aliphatic side chain assignment can be 
achieved from C(CO)NH and H(CCO)NH spectra. These two experiments provide 
information on residue types based on numbers of cross peaks on every strip as well 
as aliphatic side chain carbon and proton chemical shifts respectively. Therefore, they 
can be used to verify the backbone assignment at the same time. Figure 3.6 A and B 
shows the strips of residue from E24 to G29 from both spectra.  
Sometimes the signals of aliphatic side chain protons were not observable in 
the H(CCO)NH spectrum. In such cases, 13C-edited NOESY spectrum will be used to 
assign side chain protons, because it links the proton to its attached carbon and 
provides clusters of cross peaks at the same side chain. Especially for this kind of 
small proteins, it gives unambiguous signals in methyl group regions.  
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          A 
 
      B 
Figure 3.6  Aliphatic side chain assignments 
A. Strips from C(CO)NH spectrum (residue E24 to G29) 
        B. Strips from H(CO)NH spectrum (residue E24 to G29) 
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HCCH-TOCSY spectrum is necessary for the aliphatic side chain assignment, 
because it provides the linkage of side chain proton to carbon. Figure 3.7 shows how 




Figure 3.7 Selected 1H(F3) and 1H(F1) planes at different 13C(F2) chemical 
shifts of the HCCH-TOCSY spectrum illustrating connectivity originated 
from 13C attached protons of amino acid spin system. (T26 as an example) 
 
3.2.2 Secondary structure 
 3.2.2.1 Chemical Shift Index 
Chemical shifts experience an upfield shift when in a helix configuration (with 
respect to the random coil value) and a comparable downfield shift when in a β-strand 
extended configuration (Wishart, 1992). Based on these findings, the differences 
between Cα and Cβ chemical shift values for each residue have been calculated to 
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compare with the random coil values of same type of amino acid and predict the 
secondary structure of the protein. The secondary structure of the protein is deployed 
by plotting Cα–Cβ secondary shift against its residue number (Figure 3.8). 
Because of the incompletion of backbone assignment, there are three residues 
(L53, S56, H59) have no signals on the plot. From the plot, two regions exist in helix 
conformation; one is from residue P10 to E24, the other is from residue L35 to L46. 
Additionally, there might be short helices from P4 to D7, H59 to T61 and R67 to F70. 
For these regions, the initial NOE assignment may gives more direct information 
about the secondary structure.  
 
 
Figure 3.8  13Cα-Cβ Chemical Shift Index plot of ec314 
The secondary chemical shift of each amino acid residue is expressed as the 13Cα 
secondary shift minus the 13Cβ secondary shift. 
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 3.2.2.2 NOE analysis 
Besides Chemical Shift Index, short range (i, i+1) and medium range (i, i+2; i, 
i+3; i, i+4) NOEs can provide the most direct evidence of protein secondary structure. 
Based on NOE analysis, 2 α-helical regions (P10-E24 and E35-L46) can be well 




Figure 3.9  The secondary structure analysis based on short- and medium-range 




3.2.3 NOE assignment 
About 98% of cross peaks from the 15N-edited part of NOSEY were assigned 
while about 85% of cross peaks from the 13C-edited part of NOESY were assigned. 
The unassigned peaks included the NOE peaks from unassigned side chain protons, 
aromatic ring protons and the protons with chemical shift near 4.7ppm. The restraints 
used to calculate the structures were shown in table 4.1 below.  
Restraints type Number of restraints 
All 1189 
Inter-proton distance restraints  1015 
 Intra-residue 427 
 Sequential ( | i-j | =1 ) 276 
 Medium range ( 1< | i-j | <5 ) 192 
 Long range ( | i-j | > 5 ) 120 
Hydrogen-bond restraints (two per hydrogen bond) 40 
Dihedral angle restraints 134 
Table 3.1  Summary of the restraints used to calculate the structures 
 
 3.2.4 Structural statistics 
The structure ensemble containing 20 structures has no distance violation 
above 0.5 Å or angle violations above 5°. The backbone RMSD for residues from M1 
to E72 is 0.81 and the heavy atom RMSD is 1.32. Table 4.2 shows the structure 
statistics.  
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Structure statistics  
CYANA target function (20 structures) 2.87±0.86 
    Maximum violation for upper limits (Å) 0.44±0.15 
    Maximum violation for van der Waals (Å) 0.25±0.05 
    Maximum violation for torsion angles (deg) 8.66±2.95 
R.m.s.deviation from protein (Å) 
    Backbone atoms 0.81 
    Heavy atoms 1.32 
Ramachandran plot 
    Most favored 66% 
    Additionally allowed 31% 
    Generally allowed 2% 
    Disallowed  1% 
Table 3.2  Structural statistics for the CYANA calculation and final ensemble 
 
3.3 Discussion  
 3.3.1 Sequential assignment and secondary structure prediction 
Using 2D 1H-13C HSQC spectrum as reference, nearly complete backbone 
chemical shift assignments have been obtained by one pair of 3D NMR experiments. 
Aliphatic side chain chemical shift assignments have also been obtained by three 
TOCSY experiments. The nearly complete assignments of both backbone and side 
chain resonances provide the prerequisite information for later NOE assignment. 
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Furthermore, the secondary structure prediction based on Chemical Shift Index also 
gives some clues at the initial stage of structure determination. Moreover, short- and 
medium-range NOE assignment gives more information on the secondary structure of 
protein ec314. Based on CSI and NOE analysis, protein ec314 is composed of helical 
structure.  
 
3.3.2 Description of structure of protein ec314 
The structure of ec314 contains 3 helical regions. The long helix1 is alpha 
helix and connected to helix2 by a long loop. The helix2 is a short 3-10 helix only 
contains three residues. Helix3 is an alpha helix and almost parallel to helix1. Helix2 
and helix3 connected each other by a short turn formed by residues K38 and V39.  
Figure 4.1 shows the superposition of backbone atoms for the calculated 
structures of ec314, while Figure 4.2 shows the ribbon diagram representation of the 
protein. 
 
Figure 3.10  Stereo-view of the superposition of backbone atoms for 20 






Figure 3.11  Ribbon diagram representation of 3D structure of protein ec314 
A. Side view 
B. Top view 
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3.3.3 Helix Regions 
The helix1 region from P10 to E24 is an alpha-helix. The backbone RMSD for 
this region is 0.33. The helix2 region from L35 to Q37 is a 3-10 helix and the helix3 
region from A40 to Q45 is an alpha-helix. The backbone RMSD for these two helices 
region from L35 to L46 is 0.41. All these RMSD values suggest that the helical 
regions are very well defined.  
 
 3.3.4 Proline conformation  
All three Pro residues of ec314 adopt trans conformation. This is consistent 
with the prediction from the chemical shift values of Cβ values of these 3 proline 
residues (Grathwohl, 1976). Pro 4 is in the beginning of the first loop of the structure. 
Pro 10 is the first residue of the long alpha-helix1. Pro 66 is in the last loop of the 
structure. Therefore, the three prolines do not affect the structure calculation. 
 
3.3.5 Unstructured region and loops 
There are several regions of the structure are poorly defined. The flexible loop 
regions include loops from residue W28 to E32, from V54 to H59 and from P66 to 
Q69. It is due to lack of NOE signals in these regions.  
 
3.3.6 Comparison to similar structures 
There are six sequences show sequence identity more than 70% through 
protein-protein blast provided by NCBI. The bacterium Escherichia coli O157:H7 
EDL933 has the exact same sequence as our protein. Hypothetical protein Salmonella 
enterica serovar Typhi (str. CT18) which is the aetiological agent of typhoid fever 
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shows 87% sequence identity and putative cytoplasmic protein Salmonella tyhimrium 
LT2 which is a leading cause of human gastroenteritis shows 89% sequence identity 
to protein ec314. Hypothetical protein Yersinia pestis which is the causative agent of 
the systemic invasive infectious disease shows 76% sequence identity, Erwinia 
carotovora atroseptica SCRI1043 show 75% sequence identity and hypothetical 
protein photorhabdus luminescens laumondii TT01 shows 70% sequence identity. 
However, for all these six proteins, no structure has been published and deposited into 
Protein Data Bank.  
Compare to the three-dimensional structure of protein 1AA3, C-terminal 
domain of the escherichia coli RecA protein has similar structure to protein ec314. 
The bacterial RecA protein plays a central role in the repair of stalled replication forks, 
double-strand break repair, general recombination, induction of the SOS response and 
SOS mutagenesis. The major activity of RecA in DNA metabolism is the promotion 
of DNA strand exchange reactions. RecA is the prototype for a ubiquitous family of 
proteins but exhibits a few activities that some of its eukaryotic, archaeal, and viral 
homologous appear to lack (Cox, 2003).  Protein RecA contains 63 amino acids and 
has a molecular weight around 7 kDa. It is composed of 3 α-helices and 2 β-sheets. 
The only difference between these two structures is 2 β-sheets connect the two short 
α-helices in protein RecA (Aihara, 1997) while a short turn in protein ec314. The 










The study of brain tumor metabolites using NMR techniques shows the 
possibility of applying NMR techniques in clinical research and medical diagnosis 
and the power of NMR techniques in this area. Combining two dimensional 
experiments HSQC and COSY, the brain metabolites can be identified according to 
both their 1H and 13C chemical shifts and the correlations between protons within a 
compound. Furthermore, the high-resolution magic-angle spinning proton NMR 
spectrum can be used to calculate the concentrations of major metabolites in brain 
tumors. With the wide application of various relatively simple NMR techniques and 
improvement on the understanding of metabolites, it will become possible to use 
NMR as a tool for clinical diagnosis on brain tumor by analyzing spectra of brain 
metabolites based on the correlations between brain metabolites and brain tumors. 
The other part of study on NMR structural solution of protein is achieved by 
three steps. Firstly, near complete 1H, 13C and 15N backbone and side chain chemical 
shift assignments were obtained by pairs of three-dimensional NMR spectroscopy. 
The chemical shift gives important clues on structure study of the protein.  
Secondly, the secondary structure analysis based on the chemical shift index 
and short- and medium-range NOE assignment provides the initial impression of the 
three dimensional structure.  
Thirdly, the three dimensional structure of protein ec314 have been solved. 
Based on distance constraints from NOE assignments, hydrogen bond and dihedral 
angle, a helical structure represents protein ec314 has been calculated by CYANA. 
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The results show the first two helices in the structure are connected by long loop, and 
the helix2 and helix3 are connected to each other by a short turn.  
Comparing to the known structures of proteins, ec314 is similar to protein 
RecA which is a cyanobacterial gene product. It may help us predict the function of 
protein ec314 based on its 3D structure.  
 
Future Work 
1. On the study of brain tumor metabolites, more samples from various patients will 
be collected and studies by NMR. By analyzing the spectra, the correlation 
between metabolites and type of brain tumors will be discovered.  
2. Structure refinement of protein ec314 can be achieved by completing the aromatic 
proton assignment as more long range NOE can be assigned.  
3. Based on 3D structure, biological activity test may apply to confirm predicted 
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